logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
06/05/2026
The South Korean composite stock price index rose by 7% to 7423.47.
Latest
2 m ago
Novo Nordisk: Sales of the weight loss drug Wegovy in the first quarter were DKK 18.235 billion, exceeding the market estimate of DKK 17.396 billion.
2 m ago
Novo Nordisk: WEGOVY sales in the first quarter amounted to 18.24 billion Danish kroner.
3 m ago
Novo Nordisk expects full-year adjusted sales to decline by 4% to 12% year-on-year, compared to the previous forecast of a 5% to 13% decline.
4 m ago
Novo Nordisk: The company raised its performance expectations for 2026 due to the expected increase in sales of GLP-1 products.
4 m ago
In the first quarter of 2026, Novo Nordisk's adjusted operating profit reached 32.858 billion Danish kroner.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.